Why your partner's doctor carries the weight, explained

You have said it gently. You have said it at two in the morning. You have left the article open on the laptop. Your husband, wife, or partner still has not called anyone about the depression that two rounds of medication did not lift. If you live in St. Louis and that sounds familiar, this explainer is for you. It covers a finding that can feel deflating at first and then, on reflection, clarifying: the person most likely to move your partner is not you. It is their doctor.

What the poll found

This summer our publisher financed a poll that heard from 443 adults, Missourians and Illinoisans included, spread over ten Midwest states. A single question offered five possible messengers and asked which would actually get the respondent to give ketamine or esketamine a try for depression.

Physicians were not just first; they lapped the field. Seventy-four percent picked their own doctor. Loved ones, meaning a close friend or family member, were chosen by 18 percent. A veteran or first responder with an online following came in at 4 percent. Advertising scraped together 2 percent; podcast hosts, a lone 1 percent.

That is the full sample, a slice of the general public rather than a panel of couples. About 6 percent said they were married to or partnered with a veteran or first responder. That group was too small to report on its own, so we do not. St. Louis TV market respondents numbered just 31, a small group, and the doctor drew 68 percent of them. The figures are final, from validated data.

Why the doctor, and not the person who knows them best?

We did not ask respondents to explain, so what follows is interpretation, not data.

Authority without history. A doctor's suggestion arrives without the weight of past arguments, disappointments, or worry. When a spouse raises treatment, it can be heard as "you are not okay and I am tired of it," even when that is not the message at all.

Medical fit. Only a clinician can check the things that determine whether a treatment is safe: blood pressure, heart history, other medications, alcohol or drug use, and whether standard treatments were tried at adequate doses for long enough.

Accountability. A physician who recommends something is responsible for the recommendation and for following up. That responsibility is part of what makes the advice feel trustworthy.

How a recommendation actually gets made

It helps to see the path in stages, because it sets realistic expectations.

• The first visit. Usually primary care. The doctor screens for depression, reviews what has been tried, and looks for medical causes such as a thyroid problem or a sleep disorder. More than half the poll's respondents, 56 percent, said this is where they would start.
• The referral. For newer options, the primary doctor typically sends the patient to a psychiatrist. About a quarter of respondents, 23 percent, would go straight there.
• The evaluation. The psychiatrist decides whether the depression meets the definition of treatment-resistant, generally meaning at least two adequate antidepressant trials without enough improvement, and whether a particular treatment fits.
• The paperwork. If the treatment needs insurer approval, the office submits prior authorization with the documented history.

Where esketamine sits in that path

Spravato, the brand-name form of esketamine, is a nasal spray. It holds FDA approval for adults whose depression has resisted standard antidepressants. Each dose happens at a certified healthcare site with staff watching, and the patient hands off driving duty until the following day. It is not approved for PTSD, and it is not something your partner can pick up at a pharmacy. Brain Recovery Centers explains what the Spravato process looks like for anyone curious.

Two other things share the ketamine name and are easy to confuse with it. IV ketamine drips, which some clinics around St. Louis sell, are off-label for depression and usually self-pay. At-home ketamine lozenges prescribed through telehealth are off-label and far less supervised.

Most people have never heard any of this. The survey found that 73 percent did not know the name Spravato at all, and just 6 percent could explain what it is. If your partner looks blank when you mention it, they are in the majority.

The St. Louis wrinkle: two states, many plans

The metro area straddles the Mississippi, and so does its insurance. A partner who works in Clayton and lives in Belleville, or the reverse, may have a plan that treats Missouri and Illinois providers differently. MO HealthNet and Illinois Medicaid are separate programs with separate provider networks.

That matters, because coverage was the survey's dominant concern. A striking 85 percent listed "covered by insurance" as one of their two chief provider criteria, and just over half said they would tolerate extra hoops to keep treatment covered. Before your partner falls in love with a clinic across the river, confirm it is in network.

So what is a spouse's role?

The same survey placed family and friends second, and that is meaningful. The most effective use of that influence appears to be steering toward the exam room rather than toward a specific treatment. In practice:

• Name what you see, not what they should take.
• Offer to help write a medication history with doses, dates, and outcomes.
• Offer to book the appointment and come along.
• Ask if they would like company in the exam room, and take the answer as final.
• If a clinic treatment is prescribed, plan to drive.

This explainer offers context, not medical advice, and results vary from one patient to the next. Which option suits your partner is for their clinician to judge.

If your partner has said anything that makes you fear for their life, act on that fear now. Call 988 or send a text. Whoever answers at the Suicide and Crisis Lifeline can help a frightened spouse just as much as a person in crisis, and can talk you through the next hour. If the danger is immediate, dial 911 instead.

Methodology

Pollfish conducted this study on its consumer panel; the publisher commissioned it and covered the cost. The last responses arrived by June 23, 2026, for n=443 adults 18 to 64 residing in Missouri, Illinois, Kansas, Iowa, Indiana, Nebraska, Ohio, Oklahoma, Minnesota, and Wisconsin. Spouses and partners were too few to report as a subgroup; Pollfish's completed validation makes these the final numbers.